• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

F-FDG PET/MR在下咽癌中的诊断及预后价值

The Diagnostic and Prognostic Value of F-FDG PET/MR in Hypopharyngeal Cancer.

作者信息

Fan Cui, Huang Xinyun, Wang Hao, Hu Haixia, Wu Jichang, Miao Xiangwan, Liu Yuenan, Xiang Mingliang, Chen Nijun, Ye Bin

机构信息

Department of Otolaryngology & Head and Neck Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197 Ruijin 2nd Road, Shanghai 200025, China.

Shanghai Key Laboratory of Translational Medicine on Ear and Nose Diseases, Shanghai 200125, China.

出版信息

Diagnostics (Basel). 2025 Aug 22;15(17):2119. doi: 10.3390/diagnostics15172119.

DOI:10.3390/diagnostics15172119
PMID:40941608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12427711/
Abstract

To evaluate the diagnostic performance of fluorine 18 fluorodeoxyglucose positron emission tomography/magnetic resonance imaging (F-FDG PET/MR) in the preoperative staging of hypopharyngeal cancer (HPC), compare it with conventional enhanced computed tomography (CT) and MR, and further explore the prognostic value of its metabolic and diffusion metrics for HPC. This retrospective study included 33 patients with pathologically confirmed HPC. All patients underwent preoperative F-FDG PET/MR, CT, and MR examination. The staging performance of the three modalities was evaluated using pathological staging as a reference. Additionally, metabolic indicators and diffusion-related parameters from PET/MR were collected to investigate their impact on larynx preservation and survival. PET/MR demonstrated accuracies of 90.9% and 71.4% in the preoperative T and N staging, respectively, significantly higher than those of CT (54.5%, = 0.001; 42.9%, = 0.021) and MR (66.7%, = 0.016; 42.9%, = 0.021). On the whole, significant differences emerged in the maximum standard uptake value (SUVmax), metabolic tumor volume (MTV), minimum apparent diffusion coefficient (ADCmin), and mean ADC (ADCmean) and combined ratios across different T stages, while SUVmax, mean SUV (SUVmean), total lesion glycolysis (TLG), and MTV varied significantly across different N stages. The ADCmin and ADCmean showed good predictive capability for larynx preservation, with AUCs of 0.857 and 0.920 ( < 0.05), respectively. In Cox multivariate analysis of overall survival, high-level ADCmean ( 0.004) and low-level TLG/ADCmean ( = 0.022) were significantly associated with better survival. In HPC, F-FDG PET/MR imaging significantly surpasses CT and MR in preoperative diagnostic staging. Its diffusion-related parameters have substantial prognostic value, with high ADC values associated with larynx preservation. ADCmean and TLG/ADCmean are potential prognostic indicators for HPC.

摘要

为评估氟代脱氧葡萄糖正电子发射断层扫描/磁共振成像(F-FDG PET/MR)在下咽癌(HPC)术前分期中的诊断性能,将其与传统增强计算机断层扫描(CT)和磁共振成像(MR)进行比较,并进一步探讨其代谢和扩散指标对HPC的预后价值。这项回顾性研究纳入了33例经病理证实的HPC患者。所有患者均接受了术前F-FDG PET/MR、CT和MR检查。以病理分期为参照评估这三种检查方式的分期性能。此外,收集PET/MR的代谢指标和扩散相关参数,以研究它们对喉保留和生存的影响。PET/MR在术前T分期和N分期中的准确率分别为90.9%和71.4%,显著高于CT(54.5%,P = 0.001;42.9%,P = 0.021)和MR(66.7%,P = 0.016;42.9%,P = 0.021)。总体而言,不同T分期的最大标准摄取值(SUVmax)、代谢肿瘤体积(MTV)、最小表观扩散系数(ADCmin)、平均表观扩散系数(ADCmean)及联合比值存在显著差异,而不同N分期的SUVmax、平均标准摄取值(SUVmean)、总病变糖酵解(TLG)和MTV有显著变化。ADCmin和ADCmean对喉保留显示出良好的预测能力,曲线下面积(AUC)分别为0.857和0.920(P < 0.05)。在总生存的Cox多因素分析中,高水平的ADCmean(P = 0.004)和低水平的TLG/ADCmean(P = 0.022)与更好的生存显著相关。在HPC中,F-FDG PET/MR成像在术前诊断分期方面显著优于CT和MR。其扩散相关参数具有重要的预后价值,高ADC值与喉保留相关。ADCmean和TLG/ADCmean是HPC潜在的预后指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0cb/12427711/c52e5946fe9c/diagnostics-15-02119-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0cb/12427711/c4dcd424f95e/diagnostics-15-02119-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0cb/12427711/e688a85a3f61/diagnostics-15-02119-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0cb/12427711/1262226959c3/diagnostics-15-02119-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0cb/12427711/c52e5946fe9c/diagnostics-15-02119-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0cb/12427711/c4dcd424f95e/diagnostics-15-02119-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0cb/12427711/e688a85a3f61/diagnostics-15-02119-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0cb/12427711/1262226959c3/diagnostics-15-02119-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0cb/12427711/c52e5946fe9c/diagnostics-15-02119-g004.jpg

相似文献

1
The Diagnostic and Prognostic Value of F-FDG PET/MR in Hypopharyngeal Cancer.F-FDG PET/MR在下咽癌中的诊断及预后价值
Diagnostics (Basel). 2025 Aug 22;15(17):2119. doi: 10.3390/diagnostics15172119.
2
Prognostic value of 18F-FDG-PET/CT parameters in patients with pancreatic carcinoma: A systematic review and meta-analysis.18F-FDG-PET/CT参数对胰腺癌患者的预后价值:一项系统评价和荟萃分析
Medicine (Baltimore). 2017 Aug;96(33):e7813. doi: 10.1097/MD.0000000000007813.
3
Comparison of [Ga]Ga-FAPI-04 and [F]FDG PET/CT for detection of bone metastases of lung cancer.[镓]Ga-FAPI-04与[氟]FDG PET/CT在检测肺癌骨转移中的比较。
Quant Imaging Med Surg. 2025 Sep 1;15(9):8627-8640. doi: 10.21037/qims-2025-234. Epub 2025 Aug 18.
4
Role of Metabolic Parameters of 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (18F-FDG PET-CT) Imaging in Predicting Progression-Free Survival of Radioiodine-Refractory Differentiated Thyroid Cancer: A Single-Center Study.18F-氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描(18F-FDG PET-CT)成像的代谢参数在预测放射性碘难治性分化型甲状腺癌无进展生存期方面的作用:一项单中心研究
Cureus. 2025 May 28;17(5):e84998. doi: 10.7759/cureus.84998. eCollection 2025 May.
5
The correlation between preoperative total lesion glycolysis and lymphovascular invasion based on F-FDG PET/CT and its predictive value in primary gastric cancer: a cross-sectional study.基于F-FDG PET/CT的原发性胃癌术前总病灶糖酵解与淋巴管侵犯的相关性及其预测价值:一项横断面研究
Quant Imaging Med Surg. 2025 Sep 1;15(9):7738-7748. doi: 10.21037/qims-2025-644. Epub 2025 Aug 13.
6
Evaluation of pre-treatment F-18 FDG PET/CT according to Mandard classification in locally advanced rectal cancer patients undergoing neoadjuvant chemoradiotherapy.根据曼德尔分类法对接受新辅助放化疗的局部晚期直肠癌患者进行治疗前F-18 FDG PET/CT评估。
BMC Cancer. 2025 Aug 4;25(1):1262. doi: 10.1186/s12885-025-14659-y.
7
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.用于诊断神经母细胞瘤的123I-间碘苄胍闪烁扫描术和18F-氟代脱氧葡萄糖正电子发射断层显像
Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2.
8
Intratumoral metabolic heterogeneity by F-FDG PET/CT to predict prognosis for patients with thymic epithelial tumors.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描评估胸内上皮性肿瘤瘤内代谢异质性对预后的预测价值。
Thorac Cancer. 2024 Jun;15(18):1437-1445. doi: 10.1111/1759-7714.15331. Epub 2024 May 16.
9
Total metabolic tumor volume on F-FDG PET/CT is a game-changer for patients with metastatic lung cancer treated with immunotherapy.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的总代谢肿瘤体积是免疫治疗转移性肺癌患者的改变游戏规则的因素。
J Immunother Cancer. 2024 Apr 22;12(4):e007628. doi: 10.1136/jitc-2023-007628.
10
Significance of 18 F-fluorodeoxyglucose PET/computed tomography in the initial staging of malignant peritoneal mesothelioma.18F-氟脱氧葡萄糖正电子发射断层显像/计算机断层扫描在恶性腹膜间皮瘤初始分期中的意义
Nucl Med Commun. 2025 Aug 1;46(8):746-752. doi: 10.1097/MNM.0000000000001990. Epub 2025 May 6.

本文引用的文献

1
Current Applications of PET/MR: Part II: Clinical Applications II.当前 PET/MR 的应用:第二部分:临床应用二。
Can Assoc Radiol J. 2024 Nov;75(4):826-837. doi: 10.1177/08465371241255904. Epub 2024 Jun 5.
2
Role of F-FDG PET/CT in Head and Neck Squamous Cell Carcinoma: Current Evidence and Innovative Applications.F-FDG PET/CT在头颈部鳞状细胞癌中的作用:当前证据与创新应用
Cancers (Basel). 2024 May 16;16(10):1905. doi: 10.3390/cancers16101905.
3
Application of PET/MRI in Gynecologic Malignancies.PET/MRI在妇科恶性肿瘤中的应用。
Cancers (Basel). 2024 Apr 12;16(8):1478. doi: 10.3390/cancers16081478.
4
Preoperative metabolic parameters of F-FDG PET/CT are associated with TNM stage and prognosis of colorectal cancer patients.F-FDG PET/CT的术前代谢参数与结直肠癌患者的TNM分期及预后相关。
Quant Imaging Med Surg. 2024 Jan 3;14(1):462-475. doi: 10.21037/qims-23-966. Epub 2023 Dec 4.
5
Machine learning identifies multi-parametric functional PET/MR imaging cluster to predict radiation resistance in preclinical head and neck cancer models.机器学习识别多参数功能 PET/MR 成像簇,以预测头颈部癌症模型中的放射抵抗。
Eur J Nucl Med Mol Imaging. 2023 Aug;50(10):3084-3096. doi: 10.1007/s00259-023-06254-9. Epub 2023 May 6.
6
A nationwide study on cancer recurrences, second primary tumours, distant metastases and survival after treatment for primary head and neck cancer in the Netherlands.荷兰一项针对原发性头颈部癌症治疗后癌症复发、第二原发肿瘤、远处转移和生存情况的全国性研究。
Eur J Surg Oncol. 2023 Jul;49(7):1154-1161. doi: 10.1016/j.ejso.2023.03.209. Epub 2023 Mar 17.
7
Assessing the variability and correlation between SUV and ADC parameters of head and neck cancers derived from simultaneous PET/MRI: A single-center study.评估源于头颈部癌同步 PET/MRI 的 SUV 和 ADC 参数的变异性和相关性:一项单中心研究。
J Appl Clin Med Phys. 2023 May;24(5):e13928. doi: 10.1002/acm2.13928. Epub 2023 Feb 10.
8
Prognostic Value of 18F-Fluorodeoxyglucose-Positron Emission Tomography/Magnetic Resonance Imaging in Patients With Hypopharyngeal Squamous Cell Carcinoma.18F-氟代脱氧葡萄糖正电子发射断层扫描/磁共振成像在下咽鳞状细胞癌患者中的预后价值。
J Comput Assist Tomogr. 2022;46(6):968-977. doi: 10.1097/RCT.0000000000001365. Epub 2022 Sep 1.
9
Detection of distant metastases and distant second primary cancers in head and neck squamous cell carcinoma: comparison of [F]FDG PET/MRI and [F]FDG PET/CT.头颈部鳞状细胞癌远处转移及远处第二原发癌的检测:[F]FDG PET/MRI与[F]FDG PET/CT的比较
Insights Imaging. 2022 Jul 28;13(1):121. doi: 10.1186/s13244-022-01261-0.
10
A Role of PET/MR in Breast Cancer?正电子发射断层扫描/磁共振成像在乳腺癌中的作用?
Semin Nucl Med. 2022 Sep;52(5):611-618. doi: 10.1053/j.semnuclmed.2022.01.003. Epub 2022 Mar 5.